Home Tags Access to medicines

Tag: access to medicines

The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120 low- and middle-income countries starting...
In advance of the September 2024 WHO pandemic negotiations (INB 11), Knowledge Ecology International (KEI), Innovarte, and Medicines Law & Policy (ML&P) will convene...
We invite you to read the following article on the importance of transparency in the costs of medicines and health products, which the WHO...
On 21 May 2024, Wemos, together with KEI, Health Action International (HAI), Innovarte, Medicines Law & Policy, UAEM and Afya na Haki, organized an...
We share an interesting article from Innovarte ONG, written by Adán González, about licenses of right, a type of voluntary licenses established in some...
We share an interesting article from Innovarte ONG, which reflects on how the negotiations of the Pandemic Treaty have been diluting the principles of...